Related news and resources
The socio-economic value of adult Immunization programs (OHE)
The study “The Socio-Economic Value of Adult Immunization” by the Office of Health Economics (OHE) synthesizes existing evidence for the broad, socio-economic value of adult immunization programs. It focuses on influenza, pneumococcal, herpes zoster (HZ), and respiratory syncytial virus (RSV) programs in 10 countries where the vaccines have been publicly recommended (Australia, Brazil, France, Germany,...
Read more
The socio-economic value of adult immunization (OHE)(Poster)
This study by the Office of Health Economics (OHE) synthesizes existing evidence for the broad, socio-economic value of adult immunization programs, focusing on influenza, pneumococcal, herpes zoster (HZ), and respiratory syncytial virus (RSV) programs in ten countries (Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, United States). In a forthcoming publication, OHE will...
Read more
G20 side event on “Envisaging a Global R&D Network for Research in Vaccines, Therapeutics, and Diagnostics (VTDs) to enhance Prevention, Preparedness, and Response (PPR)”
On 6 June, IFPMA delivered a statement at the G20 “Strengthening Global Collaboration on Research and Development in MCMs (Diagnostics, Vaccines, and Therapeutics” side event on “Envisaging a Global R&D Network for Research in VTDs to enhance PPR” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read more